Re. Eckert et al., MOLECULAR MECHANISM OF THE ALPHA-1-ADRENOCEPTOR INDUCED CAVERNOUS SMOOTH-MUSCLE CONTRACTION, Aktuelle Urologie, 27, 1996, pp. 100-103
The relaxation of cavernous smooth muscle tissue is the essential step
in the initiation of penile erection which is the therapeutical goal
in the treatment of erectile dysfunction (ED) [10]. Cellular contracti
lity is determined by changes of the free intracellular Ca2+-concentra
tion [Ca2+](i) which is modulated by interactions of Ca2+-influx throu
gh voltage-dependent Ca2+-channels (I-Ca), Ca2+-release from intracell
ular, non-mitochondrial Ca2+-stores and Ca2+-extrusion systems [9,17].
Hormones, neurotransmitter and other mediators may affect cavernous s
mooth muscle contractility by modulating these cellular compartments v
ia second messengers [8,9,17]. The present study focuses on the intrac
ellular mechanism of the alpha(1)-adrenoceptor induced cavernous smoot
h muscle contraction by applying the patch-clamp technique combined wi
th the Ca2+-sensitive fluorescence dye FURA II to enzymatically disper
sed human cavernous smooth muscle myocytes. The alpha(1)-adrenoceptor
agonist norepinephrine (NE) selectively stimulated I-Ca in a dose-depe
ndent-and fully reversible fashion simultaneously elevating [Ca2+](i)
up to 1.4 mu M. The threshold concentration was 10 nM (n = 7), EC(50)
was 100 nM, maximal effects were observed in the micromolar range. Int
racellular application of inositol 1,4,5-trisphosphate (IP3) which rel
eases Ca2+ from the IP3-sensitive Ca2+-pool [1,13], imitated the NE ev
oked responses. Moreover the NE induced contraction was abolished when
the myocytes were pretreated with the intracellular Ca2+-release bloc
kers ryanodine (200 mu M, n = 11), thapsigargin (0.1 mu M, n = 12) or
low-molecular weight heparin (50 mg/ml, n = 9) [2,8,11,15,17]. These e
xperimental results indicate a coupling of alpha(1)-adrenoceptors to t
he phospholipase C (PLC) converting phosphoinositol 4,5-bisphosphate i
nto diacylglycerol (DAG), an endogenous activator of the protein kinas
e C (PKC), and IP3 which increases [Ca2+](i) by releasing Ca2+ from IP
3-sensitive Ca2+-stores [1]. The elevated [Ca2+](i) seems to be respon
sible for the stimulation of I-Ca most likely due to phosphorylation o
f voltage-dependent Ca2+-channels by the Ca2+-calmodulin dependent pro
tein kinase (CCPK). The blockade of this pathway results in cavernous
smooth muscle relaxation which could be of benefit for therapeutical a
pplications in ED.